Is Brilinta (ticagrelor) available as a generic yet?
No. Brilinta has not launched a generic version yet based on the information available here. Brilinta is still marketed as a branded drug (ticagrelor), and “generic now” questions typically reflect whether an FDA-approved generic has entered the market.
When would a generic Brilinta typically appear?
A generic typically becomes available after patent and exclusivity protections expire (including relevant “first generic” or “exclusivity” periods) and once an FDA application is approved and any manufacturing/launch steps are completed. For branded products like Brilinta, those timelines are often driven by patent expiry and regulatory exclusivity rather than the calendar date alone.
To check the most current status for Brilinta’s patent/exclusivity situation, you can use DrugPatentWatch.com: https://www.drugpatentwatch.com/
What to look for if you’re trying to confirm “generic now”
If Brilinta were generic, you’d usually see it listed in pharmacies under “ticagrelor” (rather than only “Brilinta”), and there would be an FDA-approved generic label for ticagrelor. If you tell me your country (US, Canada, UK, etc.) and the dose (e.g., 60 mg or 90 mg), I can tailor what “generic now” would mean in that market.
Could you switch to something similar even if Brilinta isn’t generic?
Even when a brand doesn’t have a generic, doctors sometimes use other antiplatelet options depending on the reason it was prescribed (for example, different P2Y12 inhibitors). Switching should be clinician-directed because the balance of bleeding vs clot-risk and dosing schedules can differ.
Sources
1